[1]肖智谦.急性冠脉综合征关联生化标记物的研究进展[J].医学信息,2018,(20):23-26.[doi:10.3969/j.issn.1006-1959.2018.20.008]
 XIAO Zhi-qian.Advances in Research on Biochemical Markers Associated with Acute Coronary Syndrome[J].Medical Information,2018,(20):23-26.[doi:10.3969/j.issn.1006-1959.2018.20.008]
点击复制

急性冠脉综合征关联生化标记物的研究进展()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
期数:
2018年20期
页码:
23-26
栏目:
综述
出版日期:
2018-10-15

文章信息/Info

Title:
Advances in Research on Biochemical Markers Associated with Acute Coronary Syndrome
文章编号:
1006-1959(2018)20-0023-04
作者:
肖智谦
广西北海市卫生学校附属医院心血管内科,广西 北海 536100
Author(s):
XIAO Zhi-qian
Department of Cardiovascular Medicine,Affiliated Hospital of Beihai Health School,Beihai 536100,Guangxi,Guangxi
关键词:
急性冠状动脉综合征标记物危险分层
Keywords:
Acute coronary syndromeMarkersRisk stratification
分类号:
R541.4
DOI:
10.3969/j.issn.1006-1959.2018.20.008
文献标志码:
A
摘要:
急性冠状动脉综合征是冠心病的一种严重类型,是以冠状动脉粥样硬化斑块破裂或侵袭,继发不同程度闭塞性血栓形成为病理基础的一组临床综合征,易损斑块、冠脉腔内血栓形成在ACS病程进展扮演重要角色。临床更迫切需要能在心肌损伤之前快速反映严重心肌缺血的标记物。本文旨在综述P选择素和超敏CRP等ACS关联生化标记物的研究进展,此类标记物因为与冠脉VP破裂和腔内血栓密切相关,引起血运的终止,导致恶性不良事件,所以能有助于方便快捷判断ACS预后和危险分层。随着检测技术改良,生化标记物更易于检测,我们应该联合检测多种指标,运用多种危险分层方法科学综合判断ACS危险性,才能正确指导ACS个体化诊治。
Abstract:
Acute coronary syndrome is a serious type of coronary heart disease. It is a group of clinical syndrome,which is characterized by rupture or invasion of coronary atherosclerotic plaque and secondary occlusion thrombosis.Intracoronary thrombosis plays an important role in the progression of ACS.There is an urgent need for markers that can quickly reflect severe myocardial ischemia before myocardial injury.The purpose of this article is to review the research progress of P-selectin and hypersensitive CRP related biochemical markers of ACS.These markers are closely related to the rupture of coronary VP and intraluminal thrombus,which lead to the termination of blood circulation and lead to malignant adverse events.So it can help to judge the prognosis and risk stratification of ACS conveniently and quickly.With the improvement of detection technology and the easier detection of biochemical markers,we should jointly detect a variety of indicators and use a variety of risk stratification methods to scientifically and synthetically judge the risk of ACS in order to correctly guide the individualized diagnosis and treatment of ACS.

参考文献/References:

[1]中华医学会心血管病学分会,中华心血管病杂志编辑委员会.非ST段抬高型急性冠状动脉综合征诊断和治疗指南(2016)[J].中华心血管病杂志,2017,45(5):359-376. [2]刘群,赵冬,刘军,等.中国ST段抬高急性冠状动脉综合征诊疗现况调查[J].中华心血管病杂志,2009,37(03):213-217. [3]方芳,张伟,乔旭柏,等.急性冠状动脉综合征患者易损斑块的临床病理分析[J].中华心血管病杂志,2011,39(09):802-806. [4]丁士芳,张运,张梅,等.斑块稳定性与炎症反应在急性冠状动脉综合征中作用的研究[J].中华心血管病杂志,2006,34(06):512-514. [5]肖智谦,龙运玲,彭湘南,等.不稳定心绞痛患者血hsCRP、P选择素水平与近期预后关系[J].心血管病防治知识,2018,4(5):19-21. [6]马建林,马立宁,张银环,等.不稳定型心绞痛合并高血压病患者血浆P-选择素和血小板变化的研究[J].中国医药,2014,9(2):145-148. [7]刘芳.老年急性冠脉综合征患者氨基末端脑钠肽前体、血小板P选择素、超敏C反应蛋白检测及对预后的影响[J].中西医结合心脑血管病杂志,2013,11(9):1062-1063. [8]肖智谦,龙运玲,彭湘南,等.P-选择素水平对不稳定心绞痛患者MACE发生率的影响[J].广西医科大学学报,2018,35(5):693-695. [9]杨礼,黄怡,罗立,等.P-选择素、高敏C反应蛋白与急性冠状动脉综合征发病的相关性研究[J].中国现代医学杂志,2014,24(8):91-93. [10]Khan SQ,Dhillon O,Kelly D,et al.Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction:comparison with plasma midregional pro-atrial natriuretic peptide:the LAMP(Leicester Acute Myocardial Infarction Peptide)study[J].J Am Coll Cardiol,2008,51(19):1857-1864. [11]刘子源,刘帅,张艳丽,等.sST2、NT-proBNP及sCD40L在急性冠脉综合征危险分层及预后评估中的临床意义[J].中西医结合心脑血管病杂志,2016,14(2):180-182. [12]Rahman MM,Alam MM,Jahan NA,et al.Prognostic Role of Multiple Cardiac Biomarkers in Newly Diagnosed Acute Coronary Syndrome Patients[J].Mymensingh Med J,2016,25(2):326-333. [13]孙艺红,王桂莲,傅媛媛,等.床旁B型利钠肽检测与全球急性冠状动脉事件注册评分对急性冠状动脉综合征患者的预后价值[J].中华心血管病杂志,2009,37(08):716-720. [14]刘文娴,赵晗.非ST段抬高急性冠状动脉综合征患者血浆N末端B型利钠肽原与GRACE评分的相关研究[J].中华心血管病杂志,2012,40(05):373-377. [15]Afsar CU,Uzun H,Yurdakul S,et al.Association of serum fetuin-A levels with heart valve calcification and other biomarkers of inflammation among persons with acute coronary syndrome[J].Clin Invest Med,2012,35(4):E206-E215. [16]Lim P,Moutereau S,Simon T,et al.Usefulness of fetuin-A and C-reactive protein concentrations for prediction of outcome in acute coronary syndromes(from the French Registry of Acute ST-Elevation Non ST-Elevation Myocardial Infarction [FAST MI])[J].Am J Cardiol,2013,111(1):31-37. [17]Lillpopp L,Tzikas S,Ojeda F,et al.Prognostic information of glycogen phosphorylase isoenzyme BB in patients with suspected acute coronary syndrome[J].Am J Cardiol,2012,110(9):1225-1230. [18]Meune C,Wahbi K,Weber S,et al.Performance of glycogen phosphorylase isoenzyme BB is weak in the detection of patients with non-ST-elevation acute coronary syndrome[J].Clin Biochem,2011,44(16):1343-1345. [19]Bozkurt S,Kaya EB,Okutucu S,et al.The diagnostic and prognostic value of first hour glycogen phosphorylase isoenzyme BB level in acute coronary syndrome[J].Cardiol J,2011,18(5):496-502. [20]Chalikias GK,Tziakas DN,Kaski JC,et al.Interleukin-18/interleikin-10 ratio is an independent predictor of recurrent coronary events during a 1-Year follow up in patents with acute coronary syndrome[J].Int J Cardiol,2007,117(3):333-339. [21]李巧汶,邱健,马骏,等.急性冠脉综合征患者血浆白介素18,白介素10及其比值的变化和意义[J].中国误诊学杂志,2008,8(14):3282-3284.

更新日期/Last Update: 2018-11-09